ProstACT Global

Advertisement

cGxPJobs Banner

Telix Presents Encouraging Phase 3 Results for TLX591-Tx at ASCO 2026

MELBOURNE, Australia & INDIANAPOLIS, U.S., June 2, 2026 Telix Pharmaceuticals announced positive Part 1 data from its global Phase...

By cGxPwire Editor
June 3, 2026

Read More

Advertisement

cGxPJobs

Directory